Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus

• Κύριοι συγγραφείς: Mohsin Kazi (Συγγραφέας), Abdulmohsen Alqahtani (Συγγραφέας), Ajaz Ahmad (Συγγραφέας), Omar M. Noman (Συγγραφέας), Mohammed S. Aldughaim (Συγγραφέας), Ali S. Alqahtani (Συγγραφέας), Fars K. Alanazi (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Control of hyperglycemia and prevention of glucose reabsorption (glucotoxicity) are important objectives in the management of type 2 diabetes. This study deals with an oral combined dosage form design for two anti-diabetic drugs, sitagliptin and dapagliflozin using self-nanoemulsifying drug delivery...